ATR Inhibitor Plus Niraparib Study in Advanced Solid Tumors and Ovarian Cancer
Clinicaltrials.gov identifier:
NCT04267939
Advanced ovarian cancer or other solid tumors
Study Contact Information:
For additional information, contact: Bayer Clinical Trials by phone: 1-888-842-2937 or by email
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer
About the Study
This study will look at how well how people with advanced ovarian, or primary peritoneal cancer or other respond to treatment with the BAY1895344 in combination with the niraparib. This study is open to participants who have had their ovarian cancer progress while on a .
This study is no longer enrolling people.
This study is no longer enrolling people.
This study is no longer enrolling people.